Developer of a healthcare platform designed for the field of diagnostics, prognostics, and prediction of treatment response in oncology. The company's platform specializes in targeted RNA sequencing with the use of proprietary probes, and unique algorithms, which allow non-invasive detection of cervical abnormalities in women who are at risk of developing cervical cancer, these tests generate a histology-independent molecular diagnosis, predict a prognosis and produce a list of potentially successful precision medicines, enabling healthcare professionals to develop personalized treatment plans for cancer patients.